UNIS Apples, page-10

First 10 Last

Share
Profile

Follow
dragon_solstice

1,121 Posts.

27/06/16

11:09

Post #: 18130382
Share

Originally posted by Unifollower ↑

Hi Archer
My thoughts are that the lawsuits will amount to nothing that will affect UNIS.
Even as precarious the financial status is, I would still invest all and 1 week ago I sold all and re-bought them same day. I wanted to determine the value of the shares owned and establish a CGT loss, for CenterLink and Taxation purposes.
I never expected to be able to claim part aged pension, but it's nice to know that my weekly income is covered whilst the share price grows. If it goes under-then so be it- but I am still confident it will work out.
UNIS has doubled its clean rooms (I believe) from initially having 11.
I believe over 200 staff are on the production side.
Doing what?
well the latest info that I have is that 3 Unifill production lines are installed.
Wearables are being hand assembled and a 5 million production line is being installed.
5 million by $25 = $125 million each year and 40% profit =$52 million profit each and every year for each line installed.
3 Unifill production lines can produce 600 million syringes- some of those are about 25 cent profit and others are up to $4 profit.
The Opti range will produce a premium profit.
Amgen scrutinized the books and products and they bought in.
The FDA has been slow to work out the rules for Biosimilars, but I believe Europe is well advanced and approvals granted.
Like others I am disappointed that I haven't bought at 6 cents, but it's only production figures that is allowing the shorting to succeed.
As for BREXIT- well it's a buyers market.
Apples in trouble in China and is running out of steam trying to out smart the competition.
UNIS has to just get a Financial Partner.
All IMO

Expand

Uni, suggest you google ATO wash sales. Selling and buying back to realise the capital loss is a no no to the tax department.

UNS Price at posting: 6.6¢ Sentiment: Hold Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 23 more messages in this thread...

First 10 Last

Add UNS (ASX) to my watchlist

UNIS Apples, page-10

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News